Dr Matthew Williams

I am a consultant Clinical Oncologist, specialising in adult brain tumours.

My NHS practice is based at Charing Cross Hospital, and I lead the Computational Oncology group at Imperial College.

My main clinical focus is on the development and clinical introduction of better treatments for brain tumour patients, with a focus on patient support.

I have led the introduction of Optune (Tumour-treating fields) for GBM in the UK and implemented the routine use of combined TMZ/Lomustine chemotherapy for patients with MGMT-methylated GBM - both treatments that are widely used in other countries.

I am also leading work in the UK around delivering stereotactic radiotherapy to patients with more brain metastases.

For patients who are interested in an appointment, I would suggest looking at HINO.org.uk which covers additional and novel treatments for brain tumour patients; for those interested in Optune (Tumour-treating Fields), please visit OptuneSupport.uk

I also work with two German groups to help patients access novel immunotherapies, and work closely with a US oncologist, Michael Castro, to try and deliver novel treatment approaches for patients in the UK.

Much of our research focuses on understanding care and outcomes at a national scale, and using digital technologies in neuro-oncology.